Clinical Trial Update: CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries [NA]

View source ↗

Summary

A continued access protocol trial evaluating ReCell combined with meshed skin graft for reducing donor-site area in acute burn injuries; results posted show saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• RECELL (Autologous cell suspension)

Snippet

Sponsor: Avita Medical | Conditions: Burns | NA | Status: COMPLETED | Results posted: 2021-05-04